MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Israel-Based Clearmind Medicine Files Patent Applications for Three Unique Combinations of...

Webinar – Integrative Harm Reduction Psychotherapy (IHRP) Rationale, Theory and Technique

PT391 – MDMA-Assisted Psychotherapy For Fibromyalgia and Other Central Sensitization Syndromes

Algernon NeuroScience Initiates Traumatic Brain Injury Research Program With DMT; Appoints...

Psychedelic Policy & Law in 2022

Psychedelics Take a Step Towards the Policy Agenda in Czechia

The Medical Potential of Psychedelics: A View from the European Union

AIMS v. DEA: Advocating for Open Access to Psilocybin Assisted Therapy

Webinar – Retreat or Clinic: Which Approach is Right for You?

Load more